1. Regulation of podoplanin expression by microRNA-29b associates with its antiapoptotic effect in angiotensin II-induced injury of human podocytes
   Andreas Eisenreich et al, 2016, Journal of Hypertension CrossRef
2. Podoplanin promotes progression of malignant pleural mesothelioma by regulating motility and focus formation
   Shinji Takeuchi et al, 2017, Cancer Science CrossRef
3. Association of high PDPN expression with pulmonary metastasis of osteosarcoma and patient prognosis
   Xincheng Wang et al, 2019, Oncology Letters CrossRef
4. Abundant expression of TIM-3, LAG-3, PD-1 and PD-L1 as immunotherapy checkpoint targets in effusions of mesothelioma patients
   Elly Marcq et al, 2017, Oncotarget CrossRef
5. Utility of a highly specific and sensitive podoplanin/D2-40, calretinin, thyroid transcription factor-1, and carcinoembryonic antigen/CD66e immunohistochemical panel in differentiating malignant pleural mesothelioma from metastatic adenocarcinoma: An Egyptian experience
   SaraE Khalifa et al, 2023, Journal of Microscopy and Ultrastructure CrossRef
6. Wild-Type IDH1 and Mutant IDH1 Opposingly Regulate Podoplanin Expression in Glioma
   Chao Sun et al, 2020, Translational Oncology CrossRef
7. Establishing a panel of chemo-resistant mesothelioma models for investigating chemo-resistance and identifying new treatments for mesothelioma
   Amanda L. Hudson et al, 2014, Scientific Reports CrossRef
8. Malignant Mesothelioma: Development to Therapy
   Joyce K. Thompson et al, 2014, Journal of Cellular Biochemistry CrossRef